VIR VIR BIOTECHNOLOGY INC
FollowCOM (common), issuer CIK 1706431
204 managers (209 13F filers) reported a position in VIR shares at 2024-12-31, 88,785,734 shares in all. 32 filers opened a position and 29 filers sold out during the quarter.
- Managers
- 204
- 13F filers
- 209
- New
- 32
- Added
- 69
- Reduced
- 69
- Sold out
- 29
- Shares held by filers
- 88,785,734
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q4 2024
Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Larson Financial Group LLC | 16 | $117 | <0.01% | 0 | 13F-HRTimeline |
| Brooklyn Investment Group | 1 | $8 | <0.01% | new | 13F-HRTimeline |
| Covestor Ltd | 27 | $0 | 0% | +16 | 13F-HRTimelineValue filed as zero, left out of ratios. |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | 0% | 0 | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |
Events
Sawaf Aziz reported holdings of VIR shares in a Form 3 filed 2026-10-06. 0001628280-26-065222
Accepted , ingested